Endocrine Today Current Issue
The following articles appeared in the print edition of Endocrine Today.
Table of Contents
- Longer studies, funding needed to address ‘substantial knowledge gaps’ on PCOS-related CVD Regina Schaffer
-
- 20 years of obesity treatment: New guidelines, semaglutide among the biggest advances Michael Monostra
- CGM granted breakthrough device designation for in-hospital use
- Endocrine Society petitions FDA to lower limit on bisphenol A Michael Monostra
- Family history of diabetes may increase risk for NAFLD Michael Monostra
- GLP-1, SGLT2 combination therapy provides largest weight loss for women with PCOS Michael Monostra
- Higher BMD, fewer fractures reported for women with PCOS at high risk for hyperandrogenism Michael Monostra
- Increasing obesity rates in type 1 diabetes associated with chronic kidney disease risk Erin T. Welsh, MA
- Legal victory helps to keep children with diabetes stay safe at school Anastasia Albanese-O'Neill, PhD ARNP CDE
-
- Meta-analysis questions strength of ties between statin-induced LDL lowering, CV outcomes Erik Swain
- Metabolic adaptation increases time to achieve weight-loss goals for premenopausal women Erin T. Welsh, MA
- Most indeterminate thyroid nodules diagnosed with repeat fine-needle aspiration Michael Monostra
- Professional organizations offer education, colleagues, personal satisfaction Jonathan D. Leffert, MD, FACP, FACE, ECNU
- Switching generic levothyroxine preparations does not affect thyroid hormone levels Michael Monostra
- US House passes bill to cap insulin cost at $35 per month Michael Monostra
- VIDEO: Fetal ultrasound helpful for assessing risks for women with thyroid disease Caroline T. Nguyen, MD
- Could hyperandrogenism in PCOS be cardioprotective?
-